Viria Sold Part of Its Shares in DNA

Viria Plc has sold part of its shares in DNA. The selling price was EUR 16.8 million, which resulted in a profit from sales for Viria exceeding EUR 13.5 million.

“There has been a positive development in the share price of DNA and we wanted to utilise that by selling part of our shareholding in DNA. DNA forms a very large part of our investments in shares, thus selling the shares is well-founded also from the point of view of spreading the risk. DNA is a well-managed company and we don’t intend to sell more shares at this stage”, says Mika Vihervuori, CEO of Viria Plc.
More information: Mika Vihervuori, CEO, tel. 040 720 2140

Loihde Advance Oy is born on 1.6.2023

Our subsidiaries Loihde Analytics and Loihde Advisory have been operating under Loihde Advance name since the beginning of 2023. The merger of the two companies will now be completed when…